PUBLISHER: Acute Market Reports | PRODUCT CODE: 1546315
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1546315
Antibiotics Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The antibiotics market refers to the global industry involved in the development, production, and distribution of antibiotics, which are medicinal substances used to treat bacterial infections. Antibiotics are among the most significant medical discoveries of the 20th century and have become fundamental in modern healthcare for treating a wide range of bacterial infections in humans, animals, and even plants. Antibiotics work by either killing bacteria or inhibiting their growth. They come in various forms, including tablets, capsules, liquids, and injections, and are categorized into several classes based on their chemical structure and mechanism of action. These classes include penicillins, tetracyclines, cephalosporins, quinolones, and macrolides, among others. Each class is effective against specific types of bacteria and is used for different kinds of infections.
The antibiotics market is estimated to grow at a CAGR of 4.35% from 2024 to 2032, driven by factors such as the prevalence of infectious diseases, rising healthcare standards globally, and the need for effective treatments for bacterial infections. The market is also influenced by the development of new antibiotics to combat antibiotic-resistant bacteria, a growing concern in the medical community. Antibiotic resistance occurs when bacteria mutate and become immune to the effects of an antibiotic, making some infections harder to treat and increasing the risk of disease spread, severe illness, and death.
Driver: Rising Prevalence of Infectious Diseases
A primary driver of the antibiotics market is the rising prevalence of infectious diseases globally. The increase in bacterial infections can be attributed to factors such as growing population densities, increased urbanization, and global travel, which facilitate the spread of infectious diseases. For example, the resurgence of diseases like tuberculosis, particularly in developing countries, has led to an increased demand for effective antibiotic treatments. Additionally, the recent COVID-19 pandemic has heightened the focus on infectious diseases, leading to a renewed emphasis on the development and stockpiling of essential antibiotics for secondary bacterial infections associated with viral diseases. The increasing incidence of hospital-acquired infections, often caused by resistant bacteria, further underscores the need for effective antibiotics.
Opportunity: Combatting Antibiotic Resistance
The antibiotics market presents a significant opportunity in combatting antibiotic resistance. The emergence of antibiotic-resistant bacteria has become a global health concern, necessitating the development of new antibiotics. This situation presents an opportunity for pharmaceutical companies and research institutions to invest in the research and development of novel antibiotics and alternative therapies. The market for antibiotics effective against multi-drug-resistant bacteria is particularly promising, as these infections are increasingly prevalent and difficult to treat. The development of new antibiotic classes and the exploration of innovative treatment strategies, such as bacteriophage therapy or antibiotic adjuvants, are areas with considerable potential.
Restraint: Stringent Regulatory Requirements
A major restraint in the antibiotics market is the stringent regulatory requirements for the approval of new drugs. The process of developing a new antibiotic and bringing it to market is lengthy, complex, and costly, involving rigorous clinical trials and regulatory scrutiny. These stringent requirements are necessary to ensure the safety and efficacy of new antibiotics but can pose significant barriers, especially for smaller pharmaceutical companies. The high costs and time involved in the drug development process can deter investment in antibiotic research, particularly given the relatively lower financial returns compared to other drug categories.
Challenge: Overuse and Misuse Leading to Resistance
A key challenge facing the antibiotics market is the overuse and misuse of antibiotics, leading to the accelerated development of antibiotic resistance. The inappropriate prescription of antibiotics for viral infections, non-compliance with treatment regimens, and the use of antibiotics in agriculture are contributing factors to this issue. This challenge is exacerbated by the lack of new antibiotics entering the market, creating a situation where existing drugs become increasingly ineffective. Addressing this challenge requires a multifaceted approach, including better stewardship of existing antibiotics, public education on the appropriate use of antibiotics, and incentives for the development of new drugs. The balancing act between ensuring access to effective antibiotics and preventing the emergence of resistance is a critical and ongoing concern in the antibiotics market.
Market Segmentation by Drug Class
In the antibiotics market, segmentation by drug class includes Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, among others. Cephalosporins have traditionally accounted for the highest revenue within this market. Their broad spectrum of activity, efficacy against a wide range of bacterial infections, and relatively low toxicity have made them highly popular in clinical settings. However, the Fluoroquinolones segment is projected to experience the highest Compound Annual Growth Rate (CAGR). This growth can be attributed to their effectiveness against a wide variety of bacterial organisms, including those that are resistant to other antibiotic classes. The expansion of indications for fluoroquinolones and the introduction of newer, more advanced generations of these drugs further contribute to their rapid market growth.
Market Segmentation by Action Mechanism
Regarding market segmentation by action mechanism, the antibiotics market is divided into categories like Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, and others. Cell Wall Synthesis Inhibitors, which include drug classes like Penicillins and Cephalosporins, have consistently generated the highest revenue. This is due to their widespread use in treating a variety of common bacterial infections and their established efficacy. However, the Protein Synthesis Inhibitors, which include Macrolides and Aminoglycosides, are expected to witness a significant growth rate. This growth is driven by their effectiveness in treating infections caused by multi-drug resistant bacteria and their utility in treating atypical infections, which are becoming more prevalent. The evolution of antibiotic resistance and the ongoing need for effective treatment options against diverse bacterial pathogens are key factors influencing the growth and revenue trends in these segments.
Market Segmentation by Region
In the geographic segmentation of the antibiotics market, various regions exhibited distinct trends influenced by healthcare infrastructure, prevalence of infectious diseases, and market accessibility. In 2023, North America, particularly the United States, held the largest revenue share in the antibiotics market, attributed to its advanced healthcare system, high healthcare spending, and the presence of major pharmaceutical companies engaged in antibiotic research and development. The region's proactive approach to infectious diseases and the high prevalence of antibiotic-resistant bacteria also contributed to this market dominance. From 2024 to 2032, the Asia-Pacific region is expected to witness the highest Compound Annual Growth Rate (CAGR). This projected growth is driven by the increasing burden of infectious diseases, rising healthcare expenditures, and improvements in healthcare infrastructure in populous countries like China and India. Moreover, the growing awareness of antibiotic resistance and the need for effective treatment options are likely to boost the market in this region.
Competitive Trends
Regarding competitive trends and key players in the antibiotics market, in 2023, the market landscape was dominated by established pharmaceutical giants like AbbVie, Inc., Pfizer Inc., Novartis AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Lupin Pharmaceuticals Inc., Viatris, Inc., Melinta Therapeutics LLC, Cipla, Inc., Shionogi & Co., Ltd., KYORIN Pharmaceutical Co., Ltd., GSK Plc, and Nabriva Therapeutics PLC. These companies led the market through a combination of extensive R&D initiatives, robust drug pipelines, and strategic global distribution networks. Their strategies included focusing on the development of new antibiotics to combat resistant strains, as well as enhancing existing treatments. Moving forward from 2024 to 2032, the market is expected to become increasingly competitive with the entry of new players and the growth of smaller biotech firms specializing in antibiotic research. The key strategies are likely to involve innovation in antibiotic development, particularly in addressing multi-drug resistant bacteria, and partnerships with government and healthcare organizations to ensure widespread accessibility of these essential drugs. Additionally, efforts towards antibiotic stewardship and the development of alternative therapies to reduce antibiotic resistance are expected to shape the competitive landscape. The focus on overcoming the challenge of antibiotic resistance while meeting the global demand for effective treatments will drive the dynamics of the antibiotics market.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Antibiotics market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Antibiotics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
7-ACA
- Others
Type
- Branded Antibiotics
- Generic Antibiotics
Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Antibiotics market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Antibiotics market?
Which is the largest regional market for Antibiotics market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Antibiotics market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Antibiotics market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Antibiotics Market
- 2.2. Global Antibiotics Market, By Drug Class, 2023 (US$ Million)
- 2.3. Global Antibiotics Market, By Type, 2023 (US$ Million)
- 2.4. Global Antibiotics Market, By Action Mechanism, 2023 (US$ Million)
- 2.5. Global Antibiotics Market, By Geography, 2023 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2023
3. Antibiotics Market: Competitive Analysis
- 3.1. Market Positioning of Key Antibiotics Market Vendors
- 3.2. Strategies Adopted by Antibiotics Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Antibiotics Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Antibiotics Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Cephalosporin
- 5.3.2. Penicillin
- 5.3.3. Fluoroquinolone
- 5.3.4. Macrolides
- 5.3.5. Carbapenems
- 5.3.6. Aminoglycosides
- 5.3.7. Sulfonamides
- 5.3.8. 7-ACA
- 5.3.9. Others
6. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Branded Antibiotics
- 6.3.2. Generic Antibiotics
7. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2023 Versus 2032
- 7.3. Market Segmentation
- 7.3.1. Cell Wall Synthesis Inhibitors
- 7.3.2. Protein Synthesis Inhibitors
- 7.3.3. DNA Synthesis Inhibitors
- 7.3.4. RNA Synthesis Inhibitors
- 7.3.5. Mycolic Acid Inhibitors
- 7.3.6. Others
8. North America Antibiotics Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 8.3. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 8.4. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 8.5.Antibiotics Market: By Region, 2022-2032, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 8.5.1.1.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 8.5.1.1.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 8.5.1.2.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 8.5.1.2.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 8.5.1.3.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 8.5.1.3.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Antibiotics Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.3. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.4. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.Antibiotics Market: By Region, 2022-2032, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.5.1.1.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.5.1.1.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.5.1.2.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.5.1.2.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.5.1.3.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.5.1.3.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.5.1.4.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.5.1.4.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.5.1.5.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.5.1.5.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 9.5.1.6.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 9.5.1.6.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Antibiotics Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.3. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.4. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.Antibiotics Market: By Region, 2022-2032, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.5.1.1.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.5.1.1.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.5.1.2.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.5.1.2.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.5.1.3.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.5.1.3.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.5.1.4.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.5.1.4.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.5.1.5.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.5.1.5.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 10.5.1.6.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 10.5.1.6.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Antibiotics Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 11.3. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 11.4. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 11.5.Antibiotics Market: By Region, 2022-2032, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 11.5.1.1.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 11.5.1.1.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 11.5.1.2.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 11.5.1.2.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 11.5.1.3.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 11.5.1.3.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Antibiotics Market, 2022-2032, USD (Million)
- 12.1. Market Overview
- 12.2. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 12.3. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 12.4. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 12.5.Antibiotics Market: By Region, 2022-2032, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 12.5.1.1.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 12.5.1.1.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 12.5.1.2.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 12.5.1.2.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Antibiotics Market: By Drug Class, 2022-2032, USD (Million)
- 12.5.1.3.2. Antibiotics Market: By Type, 2022-2032, USD (Million)
- 12.5.1.3.3. Antibiotics Market: By Action Mechanism, 2022-2032, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. AbbVie, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Pfizer Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Novartis AG
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Merck & Co., Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Teva Pharmaceutical Industries Ltd.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Lupin Pharmaceuticals, Inc.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Viatris, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Melinta Therapeutics LLC
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Cipla, Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Shionogi & Co., Ltd.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. KYORIN Pharmaceutical Co., Ltd.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. GSK Plc
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. Nabriva Therapeutics PLC
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
- 13.14. Other Notable Players
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Portfolio
- 13.14.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 2 Global Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 3 Global Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 4 North America Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 5 North America Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 6 North America Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 7 U.S. Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 8 U.S. Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 9 U.S. Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 10 Canada Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 11 Canada Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 12 Canada Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 13 Rest of North America Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 14 Rest of North America Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 15 Rest of North America Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 16 UK and European Union Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 17 UK and European Union Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 18 UK and European Union Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 19 UK Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 20 UK Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 21 UK Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 22 Germany Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 23 Germany Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 24 Germany Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 25 Spain Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 26 Spain Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 27 Spain Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 28 Italy Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 29 Italy Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 30 Italy Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 31 France Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 32 France Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 33 France Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 34 Rest of Europe Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 35 Rest of Europe Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 36 Rest of Europe Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 37 Asia Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 38 Asia Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 39 Asia Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 40 China Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 41 China Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 42 China Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 43 Japan Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 44 Japan Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 45 Japan Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 46 India Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 47 India Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 48 India Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 49 Australia Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 50 Australia Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 51 Australia Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 52 South Korea Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 53 South Korea Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 54 South Korea Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 55 Latin America Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 56 Latin America Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 57 Latin America Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 58 Brazil Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 59 Brazil Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 60 Brazil Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 61 Mexico Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 62 Mexico Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 63 Mexico Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 64 Rest of Latin America Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 65 Rest of Latin America Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 66 Rest of Latin America Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 67 Middle East and Africa Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 68 Middle East and Africa Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 69 Middle East and Africa Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 70 GCC Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 71 GCC Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 72 GCC Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 73 Africa Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 74 Africa Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 75 Africa Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
- TABLE 76 Rest of Middle East and Africa Antibiotics Market By Drug Class, 2022-2032, USD (Million)
- TABLE 77 Rest of Middle East and Africa Antibiotics Market By Type, 2022-2032, USD (Million)
- TABLE 78 Rest of Middle East and Africa Antibiotics Market By Action Mechanism, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Antibiotics Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Antibiotics Market: Quality Assurance
- FIG. 5 Global Antibiotics Market, By Drug Class, 2023
- FIG. 6 Global Antibiotics Market, By Type, 2023
- FIG. 7 Global Antibiotics Market, By Action Mechanism, 2023
- FIG. 8 Global Antibiotics Market, By Geography, 2023
- FIG. 9 Market Geographical Opportunity Matrix - Global Antibiotics Market, 2023
FIG. 10Market Positioning of Key Antibiotics Market Players, 2023
FIG. 11Global Antibiotics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 12 Global Antibiotics Market, By Drug Class, 2023 Vs 2032, %
- FIG. 13 Global Antibiotics Market, By Type, 2023 Vs 2032, %
- FIG. 14 Global Antibiotics Market, By Action Mechanism, 2023 Vs 2032, %
- FIG. 15 U.S. Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 16 Canada Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 17 Rest of North America Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 18 UK Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 19 Germany Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 20 Spain Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 21 Italy Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 22 France Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 23 Rest of Europe Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 24 China Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 25 Japan Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 26 India Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 27 Australia Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 28 South Korea Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 29 Rest of Asia Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 30 Brazil Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 31 Mexico Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 32 Rest of Latin America Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 33 GCC Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 34 Africa Antibiotics Market (US$ Million), 2022 - 2032
- FIG. 35 Rest of Middle East and Africa Antibiotics Market (US$ Million), 2022 - 2032
